KMTS Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio—
EPS (TTM)$-5.460.0% YoY
Profit margin-173.0%HEALTHCARE
Market cap$1.11BSmall cap
Wall Street coverage
$27.71median target· current $21.84 (+26.9%)7 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- 3.88
- P/S (TTM)
- 13.25
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- -92.6%
- Operating margin
- -141.6%
- Revenue growth YoY
- 62.7%
- Dividend yield
- —
- Beta
- —
Last earnings
Mar 18, 2026 · Estimate $-0.60 · Reported $-0.40
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Kestra Medical Technologies, Ltd. Common Stock
Company profileKestra Medical Technologies, Ltd. is a wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington.
Classification
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 3933 LAKE WASHINGTON BLVD NE, KIRKLAND, WA
- Fiscal year end
- April
- Latest quarter
- Jan 31, 2026
Market cap$1.11B
Shares outstanding$58.4M
52W high$30.00
52W low$13.25
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent